Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A roadmap for the Human Developmental Cell Atlas

    Research output: Contribution to journalReviewResearchpeer-review

  2. Repositioning of the global epicentre of non-optimal cholesterol

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Germline Elongator mutations in Sonic Hedgehog medulloblastoma

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Pan-cancer analysis of whole genomes

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Systematic dissection of transcriptional regulatory networks by genome-scale and single-cell CRISPR screens

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Clinical impact of clonal hematopoiesis in patients with lymphoma undergoing ASCT: a national population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

The discovery of drivers of cancer has traditionally focused on protein-coding genes1-4. Here we present analyses of driver point mutations and structural variants in non-coding regions across 2,658 genomes from the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium5 of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA). For point mutations, we developed a statistically rigorous strategy for combining significance levels from multiple methods of driver discovery that overcomes the limitations of individual methods. For structural variants, we present two methods of driver discovery, and identify regions that are significantly affected by recurrent breakpoints and recurrent somatic juxtapositions. Our analyses confirm previously reported drivers6,7, raise doubts about others and identify novel candidates, including point mutations in the 5' region of TP53, in the 3' untranslated regions of NFKBIZ and TOB1, focal deletions in BRD4 and rearrangements in the loci of AKR1C genes. We show that although point mutations and structural variants that drive cancer are less frequent in non-coding genes and regulatory sequences than in protein-coding genes, additional examples of these drivers will be found as more cancer genomes become available.

Original languageEnglish
JournalNature
Volume578
Issue number7793
Pages (from-to)102-111
Number of pages10
ISSN0028-0836
DOIs
Publication statusPublished - Feb 2020

ID: 59266312